Profilo
Peter Alff has held director positions at Actinobac Biomed, Symbiotix Biotherapies, and Opera Therapeutics.
He currently holds positions as Director at Actinobac Biomed and Symbiotix Biotherapies, and as President & Director at Opera Therapeutics.
Posizioni attive di Peter Alff
Società | Posizione | Inizio |
---|---|---|
Actinobac Biomed, Inc.
Actinobac Biomed, Inc. Pharmaceuticals: MajorHealth Technology Actinobac Biomed, Inc. operates as a biopharmaceutical company developing therapeutics. It offers therapeutics for indications, including blood cancers, autoimmune, inflammatory diseases and HIV. The company was founded by Scott C. Kachlany in 2009 and is headquartered in Kendall Park, NJ. | Direttore/Membro del Consiglio | - |
Opera Therapeutics, Inc.
Opera Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Opera Therapeutics, Inc. develops next-generation treatments therapeutics for ocular and neurological diseases. The company was founded in 2017 and is headquartered in New York, NY. | Presidente | - |
Symbiotix Biotherapies, Inc.
Symbiotix Biotherapies, Inc. BiotechnologyHealth Technology Symbiotix Biotherapies, Inc. develops a novel class of molecular therapeutics based on the human microbiome. It delivers first-in-class oral agents that improve the lives of patients with inflammatory bowel disease (IBD), multiple sclerosis (MS) and other serious immune-mediated diseases. The company was founded by Lloyd Kasper, Nader Yaghoubi, Sarkis Mazmanian and Dennis Kasper in 2009 and is headquartered in Boston, MA. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
Actinobac Biomed, Inc.
Actinobac Biomed, Inc. Pharmaceuticals: MajorHealth Technology Actinobac Biomed, Inc. operates as a biopharmaceutical company developing therapeutics. It offers therapeutics for indications, including blood cancers, autoimmune, inflammatory diseases and HIV. The company was founded by Scott C. Kachlany in 2009 and is headquartered in Kendall Park, NJ. | Health Technology |
Opera Therapeutics, Inc.
Opera Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Opera Therapeutics, Inc. develops next-generation treatments therapeutics for ocular and neurological diseases. The company was founded in 2017 and is headquartered in New York, NY. | Health Technology |
Symbiotix Biotherapies, Inc.
Symbiotix Biotherapies, Inc. BiotechnologyHealth Technology Symbiotix Biotherapies, Inc. develops a novel class of molecular therapeutics based on the human microbiome. It delivers first-in-class oral agents that improve the lives of patients with inflammatory bowel disease (IBD), multiple sclerosis (MS) and other serious immune-mediated diseases. The company was founded by Lloyd Kasper, Nader Yaghoubi, Sarkis Mazmanian and Dennis Kasper in 2009 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Peter Alff